CARsgen Therapeutics Holdings Limited

SEHK:2171 Stock Report

Market Cap: HK$3.9b

CARsgen Therapeutics Holdings Management

Management criteria checks 3/4

We currently do not have sufficient information about the CEO.

Key information

Zonghai Li

Chief executive officer

CN¥2.1m

Total compensation

CEO salary percentage50.2%
CEO tenure3.8yrs
CEO ownershipn/a
Management average tenure3.2yrs
Board average tenure4.2yrs

Recent management updates

Recent updates

Is CARsgen Therapeutics Holdings (HKG:2171) Using Debt Sensibly?

Aug 31
Is CARsgen Therapeutics Holdings (HKG:2171) Using Debt Sensibly?

CARsgen Therapeutics Holdings (HKG:2171) Is In A Good Position To Deliver On Growth Plans

Jan 23
CARsgen Therapeutics Holdings (HKG:2171) Is In A Good Position To Deliver On Growth Plans

Companies Like CARsgen Therapeutics Holdings (HKG:2171) Are In A Position To Invest In Growth

Sep 05
Companies Like CARsgen Therapeutics Holdings (HKG:2171) Are In A Position To Invest In Growth

CEO Compensation Analysis

How has Zonghai Li's remuneration changed compared to CARsgen Therapeutics Holdings's earnings?
DateTotal CompensationSalaryCompany Earnings
Jun 30 2024n/an/a

-CN¥695m

Mar 31 2024n/an/a

-CN¥721m

Dec 31 2023CN¥2mCN¥1m

-CN¥748m

Sep 30 2023n/an/a

-CN¥834m

Jun 30 2023n/an/a

-CN¥920m

Mar 31 2023n/an/a

-CN¥906m

Dec 31 2022CN¥2mCN¥1m

-CN¥892m

Compensation vs Market: Zonghai's total compensation ($USD287.63K) is about average for companies of similar size in the Hong Kong market ($USD392.59K).

Compensation vs Earnings: Zonghai's compensation has increased whilst the company is unprofitable.


CEO

Zonghai Li (50 yo)

3.8yrs

Tenure

CN¥2,084,000

Compensation

Dr. Zonghai Li M.D., Ph D., is Co-Founder of CARsgen Therapeutics Holdings Limited and serves as its Chief Executive Officer and Chief Scientific Officer since February 2021 & Chairman of the Board. He ser...


Leadership Team

NamePositionTenureCompensationOwnership
Zonghai Li
Co-Founder3.8yrsCN¥2.08mno data
Huamao Wang
Co-Founder3.8yrsCN¥2.11mno data
Hua Jiang
Executive Director2.3yrsCN¥1.39mno data
Hong Ma
Senior Vice President of Clinical Developmentno datano datano data
Leigh Hsu
Senior Vice President of Business Developmentno datano datano data
Raffaele Baffa
Chief Medical Officer2.6yrsno datano data
Sylvie Peltier
Senior Vice President of Global Regulatory Affairs2.1yrsno datano data
Wing Yat Lui
Company Secretary3.8yrsno datano data

3.2yrs

Average Tenure

51yo

Average Age

Experienced Management: 2171's management team is considered experienced (3.2 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Zonghai Li
Co-Founder6.8yrsCN¥2.08mno data
Huamao Wang
Co-Founder6.2yrsCN¥2.11mno data
Hua Jiang
Executive Director2.3yrsCN¥1.39mno data
Ronggang Xie
Non-Executive Director4.2yrsno datano data
Xiangke Zhao
Independent Non-Executive Director1.3yrsCN¥80.00kno data
Bingsen Guo
Non-Executive Director6.2yrsno data1.62%
HK$ 62.4m
Guangmei Yan
Independent Non-Executive Director3.4yrsCN¥222.00kno data
Huaqing Guo
Non-Executive Director4.2yrsno data0.38%
HK$ 14.6m
Wen Zhou
Independent Non-Executive Directorless than a yearno datano data

4.2yrs

Average Tenure

47yo

Average Age

Experienced Board: 2171's board of directors are considered experienced (4.2 years average tenure).